According to Newbury Pharmaceuticals AB latest financial reports the total liabilities of NEWBRY is $2.31M, an increase of 29.79% to 2022. At the end of 2022 company had $1.78M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Newbury Pharmaceuticals AB is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $2.31M | 29.79% |
2022 | $1.78M | 317.95% |
2021 | $425.04K | - |